Effect on cardiac function among patients with type 2 diabetes following high-dose mineralocorticoid receptor antagonist using echocardiography; data from the MIRAD randomized clinical trial

Abstract Background Early heart failure prevention is central in patients with type 2 diabetes, and mineralocorticoid receptor antagonists (MRAs) have shown to improve prognosis. We investigated the effect of high-dose MRA, eplerenone, on cardiac function and structure in patients with type 2 diabet...

Full description

Bibliographic Details

Published in:	BMC Cardiovascular Disorders
Main Authors:	Niels H. Brandt-Jacobsen, Marie Louise Johansen, Jon J. Rasmussen, Morten Dalsgaard, Thomas Kumler, Jens Faber, Patrick Rossignol, Morten Schou, Caroline Kistorp
Format:	Article
Language:	English
Published:	BMC 2023-03-01
Subjects:	Mineralocorticoid receptor antagonist High-dose eplerenone Global longitudinal strain Systolic and diastolic function
Online Access:	https://doi.org/10.1186/s12872-023-03183-1